This roundup is supposed to focus on among the most notable funding rounds of the month and isn’t meant to be complete.
Well being tech corporations made a number of main funding bulletins in December. Here’s a checklist of among the greatest funding rounds.
ŌURA raises $200 million in Sequence D funding
ŌURA, which was based in Finland in 2013, offers a sensible ring referred to as the Oura Ring and an accompanying app. The ring gives personalised insights and steering on sleep, exercise, readiness, stress, resilience, ladies’s well being and coronary heart well being.
Constancy Administration & Analysis Firm and Dexcom participated in ŌURA’s $200 million Sequence D spherical. ŌURA has raised greater than $550 million so far, and its Sequence D spherical brings its valuation to $5.2 billion. The funding will help the corporate in increasing its product choices and exploring potential acquisitions.
Cleerly secures $106 million in Sequence C funding
Denver-based Cleerly makes use of FDA-cleared synthetic intelligence-powered options to allow detailed phenotyping of coronary artery illness, primarily based on superior non-invasive CT imaging.
Its $106 million funding elevate was led by Perception Companions and joined by Battery Ventures with participation from pre-existing buyers. The funding will assist Cleerly “proceed to scale its industrial progress and medical proof era, serving to well being care professionals enhance outcomes for sufferers throughout the coronary care pathway,” the announcement stated.
Rework Well being snags greater than $100 million
Indianapolis, Indiana-based Rework Well being helps employers and staff construct and entry Particular person Protection Well being Reimbursement Association (ICHRA) plans. ICHRA permits employers to offer staff a month-to-month allowance of tax-free cash that they’ll use to purchase healthcare companies for his or her wants. Rework Well being’s companies embrace plan creation and administration, name middle help, automated quoting and worker onboarding.
The $100 million in financing is from Oak HC/FT and Hercules Capital. The funding will assist the corporate increase nationally, advance its platform capabilities and develop its partnerships with brokers, businesses and carriers.
Cala Well being raises $50 million
San Mateo, California-based Cala Well being is a bioelectronic medication firm. It gives FDA-cleared, noninvasive units for hand tremors.
The $50 million elevate was co-led by Vertex Progress Fund and Nexus NeuroTech Ventures and included participation from Motion Potential, Johnson & Johnson, Lightstone, Lux Capital, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
Soda Well being secures $50 million in Sequence B funding
Bentonville, Arkansas-based Soda Well being connects well being plans and their members with a community of shops to help advantages for meals, well being merchandise and pharmacy companies. It offers a sensible advantages card that members can use on authorised items and companies. As well as, prospects obtain an evaluation to assist them discover care gaps and enhance star rankings. Soda Well being additionally gives instruments to assist well being plans simulate totally different combos of well being advantages.
The $50 million Sequence B financing spherical was led by Basic Catalyst and included participation from former Humana CEO Bruce Broussard, Lightspeed Enterprise Companions, Outline Ventures, Qiming Enterprise Companions USA and SVB Capital. Soda Well being has raised $100 million in complete. The corporate will use the financing to scale its operations, launch new knowledge merchandise and increase to new profit classes.
Image: Feodora Chiosea, Getty Photos
